At meeting held on 31 July 2021
The Board of Directors of Rossari Biotech at its meeting held on 31 July 2021 has resolved to make a strategic investment by acquiring and/or subscribing to equity shares equivalent to 50.10% of the issued and paid-up share capital of Romakk Chemicals (Romakk) and accordingly, enter into a Share Subscription Share Purchase and Shareholders Agreement to regulate the rights and obligations of the shareholders of Romakk inter-se and for the internal management.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content